BELGIUM - Starting off 2021 on a strong foot, the supermarket chain Lidl has announced strategic plans to open 23 new stores across Belgium by the end of February 2022. The retailer has also revealed some of its existing locations will be renewed and relocated.According to a release from the company, these projects are part of Lidl’s expansion strategy to open larger sales
News: Hersteller- und Händlerumfrage auf mit-Pferden-reisen de: Pferdeanhänger-Trends 2021
auto-presse.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from auto-presse.de Daily Mail and Mail on Sunday newspapers.
Hersteller- und Händlerumfrage auf mit-Pferden-reisen de: Pferdeanhänger-Trends 2021 :: motor-traffic
motor-traffic.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from motor-traffic.de Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, Feb. 18, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today an amendment of the agreement with Vyera Pharmaceuticals AG ( Vyera ) for the development of SLS-002 (intranasal racemic ketamine) to repurchase in cash a significant portion of the royalties payable on any future net sales of SLS-002.
On March 6, 2018, Seelos entered into an asset purchase agreement with Vyera, currently known as Phoenixus AG, to acquire the assets and liabilities of Vyera s intranasal racemic ketamine program, which Seelos now calls SLS-002. As additional consideration to certain upfront cash and equity payments and success-based milestone payments contemplated under the prior agreement, Seelos agreed to pay a mid-teens percentage royalty on any future net sales of SLS-002. Under this amendme